Skip to main content
A scary good deal on trusted journalism
Get full digital access to globeandmail.com
$0.99
per week for 24 weeks SAVE OVER $140
OFFER ENDS OCTOBER 31
A scary good deal on trusted journalism
$0.99
per week
for 24 weeks
SAVE OVER $140
OFFER ENDS OCTOBER 31
Start Today
// //
Flash Sale $0.99/24 weeks
Register
AdChoices

Vertex Pharmaceutic NASDAQ: VRTX-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time
Alerts Watchlist Portfolio

Today's Trading

Day Low 182.51
Day High 186.14
Open:183.52
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Latest
number cruncher
Twenty U.S. growth stocks with high reinvestment rates and earnings momentum
Subscriber content
investment ideas
Deals, data buzz could help biotech shares exit Wall Street’s ‘no man’s land’
number cruncher
These 10 U.S. large-cap stocks demonstrate consistent, solid profitability
Subscriber content
number cruncher
Strong cash flow for tumultuous times: Check out these 14 S&P 500 stocks
Subscriber content
number cruncher
These S&P 500 stocks see their sales grow despite difficult times
Subscriber content
top links
Gen Z spending habits pose risks for auto, meat and alcohol industries
Subscriber content
Description
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

View Earnings zacks

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy
View Estimates zacks

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDF Refinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDF StockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Free PDF ValueEngine logo

Latest Press Releases

More Stories
Vertex to Announce Third-Quarter 2021 Financial Results on November 2
Business Wire - Fri Oct 22, 7:00AM CDT
Business Wire - PRTGAM
Fri Oct 22, 7:00AM CDT
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third-quarter 2021 financial results on Tuesday, November 2, 2021 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access...
Vertex, Incyte fall; Precigen, Magnachip rise
Associated Press - Fri Jun 11, 3:20PM CDT
Associated Press - AP
Fri Jun 11, 3:20PM CDT
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:
Campbell Soup, Comtech fall; Merck, Vertex rise
Associated Press - Wed Jun 9, 3:17PM CDT
Associated Press - AP
Wed Jun 9, 3:17PM CDT
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 176.36 +4.89% increase
on 10/06/21
Period Open:183.61
Price movement based on the high, low and last over the given period.
187.88 -1.54% decrease
on 10/20/21
 +1.38 (+0.75%) increase
since 09/24/21
3-Month 176.36 +4.89% increase
on 10/06/21
Period Open:200.50
Price movement based on the high, low and last over the given period.
204.88 -9.71% decrease
on 07/28/21
 -15.51 (-7.74%) decrease
since 07/23/21
52-Week 176.36 +4.89% increase
on 10/06/21
Period Open:211.58
Price movement based on the high, low and last over the given period.
242.99 -23.87% decrease
on 01/25/21
 -26.59 (-12.57%) decrease
since 10/23/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies